BIO-TECHNE Corp — Director's Dealing 2014

Aug 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2014-08-12

Reporting Person: EANSOR N DAVID (SVP - Novus Biologicals)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-12	Stock Option (Right to Buy)	$94.35	A	15000	Acquired	2021-08-12	Common Stock (15000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$		Common Stock (5000)	5000	Direct

Footnotes

F1: Vests 3,750 on each of 8/12/15, 8/12/16, 8/12/17, and 8/12/18.

F2: Each restricted stock unit represents a contingent right to receive one share of Techne Corporation common stock.

F3: The restricted stock units vest in three equal annual installments beginning July 1, 2015. Shares will be delivered to the reporting person following vesting.